Cardiovascular Drugs and Therapy : Impact Factor & More
eISSN: 1573-7241pISSN: 0920-3206
Share this on:
Key Metrics
CiteScore 
5.6
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q1Pharmacology
SNIP
0.93
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cardiovascular Drugs and Therapy
Cardiovascular Drugs and Therapy Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1987 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Cardiovascular Drugs and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cardiovascular Drugs and Therapy
From Peripheral Immune Signatures to Cardiac Remodeling: Interpreting the Monocyte Axis in Hypertension-Related Atrial Fibrillation.
- 14 May 2026
- Cardiovascular drugs and therapy
Baxdrostat and Aldosterone Synthase Inhibitors: A New Class for Treatment-resistant Hypertension.
- 13 May 2026
- Cardiovascular drugs and therapy
DTX1 Regulates Aortic Dissection Progression by Modulating Vascular Smooth Muscle Cell Phenotypic Switching via Ubiquitination of ITGA5.
- 6 May 2026
- Cardiovascular drugs and therapy
NR1D2 Knockdown Alleviates Myocardial Infarction through Nrf2 Signaling Pathway Activation.
- 4 May 2026
- Cardiovascular drugs and therapy
From Mechanism to Therapy: Establishing an Integrated Framework for the Regulation and Intervention of Matrix Vesicles in Vascular Calcification.
- 27 Apr 2026
- Cardiovascular drugs and therapy
Molecular Mechanisms Underlying the Comorbidity of Type 2 Diabetes Mellitus and Coronary Artery Disease: from Insulin Resistance and Inflammation to Endothelial Dysfunction and Therapeutic Implications.
- 25 Apr 2026
- Cardiovascular drugs and therapy
From Peripheral Immune Signatures to Cardiac Remodeling: Interpreting the Monocyte Axis in Hypertension-Related Atrial Fibrillation.
- 14 May 2026
- Cardiovascular drugs and therapy
Baxdrostat and Aldosterone Synthase Inhibitors: A New Class for Treatment-resistant Hypertension.
- 13 May 2026
- Cardiovascular drugs and therapy
DTX1 Regulates Aortic Dissection Progression by Modulating Vascular Smooth Muscle Cell Phenotypic Switching via Ubiquitination of ITGA5.
- 6 May 2026
- Cardiovascular drugs and therapy
NR1D2 Knockdown Alleviates Myocardial Infarction through Nrf2 Signaling Pathway Activation.
- 4 May 2026
- Cardiovascular drugs and therapy
From Mechanism to Therapy: Establishing an Integrated Framework for the Regulation and Intervention of Matrix Vesicles in Vascular Calcification.
- 27 Apr 2026
- Cardiovascular drugs and therapy
Molecular Mechanisms Underlying the Comorbidity of Type 2 Diabetes Mellitus and Coronary Artery Disease: from Insulin Resistance and Inflammation to Endothelial Dysfunction and Therapeutic Implications.
- 25 Apr 2026
- Cardiovascular drugs and therapy
FAQs on Cardiovascular Drugs and Therapy
How long has Cardiovascular Drugs and Therapy been actively publishing? 
What is the publishing frequency of Cardiovascular Drugs and Therapy?
How many articles did Cardiovascular Drugs and Therapy publish last year?
What is the eISSN & pISSN for Cardiovascular Drugs and Therapy?
What is Citescore for Cardiovascular Drugs and Therapy?
What is SNIP score for Cardiovascular Drugs and Therapy?
What is the SJR for Cardiovascular Drugs and Therapy?
Who is the publisher of Cardiovascular Drugs and Therapy?
